found that ACE inhibitors and ARB offer partial cardiovascular protection by increasing ACE2, and that IV recombinant ACE2 may be beneficial in preventing pulmonary arterial hypertension and acute lung injury.41 The gene discussed is ACE2; the disease is pulmonary arterial hypertension.